May 16, 2017 - By Nellie Frank
Among 4 analysts covering Regenxbio (NASDAQ:RGNX), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Regenxbio had 4 analyst reports since October 12, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Monday, October 12 by Bank of America. Morgan Stanley initiated the shares of RGNX in report on Tuesday, October 13 with “Overweight” rating. The stock of Regenxbio Inc (NASDAQ:RGNX) earned “Buy” rating by Chardan Capital Markets on Tuesday, October 20. The firm has “Overweight” rating by Piper Jaffray given on Monday, October 12. See Regenxbio Inc (NASDAQ:RGNX) latest ratings:
New Amsterdam Partners Llc increased Sanderson Farms Inc (SAFM) stake by 169.59% reported in 2016Q4 SEC filing. New Amsterdam Partners Llc acquired 50,072 shares as Sanderson Farms Inc (SAFM)’s stock declined 2.03%. The New Amsterdam Partners Llc holds 79,598 shares with $7.50M value, up from 29,526 last quarter. Sanderson Farms Inc now has $2.60 billion valuation. The stock rose 0.16% or $0.18 reaching $113.65 per share. About 89,598 shares traded. Sanderson Farms, Inc. (NASDAQ:SAFM) has risen 20.95% since October 6, 2016 and is uptrending. It has outperformed by 10.30% the S&P500.
Among 9 analysts covering Sanderson Farms Inc. (NASDAQ:SAFM), 5 have Buy rating, 2 Sell and 2 Hold. Therefore 56% are positive. Sanderson Farms Inc. had 16 analyst reports since August 26, 2015 according to SRatingsIntel. The company was initiated on Wednesday, October 5 by DA Davidson. On Monday, March 27 the stock rating was upgraded by KeyBanc Capital Markets to “Overweight”. Sidoti downgraded the shares of SAFM in report on Friday, November 20 to “Neutral” rating. On Monday, December 12 the stock rating was upgraded by Sidoti to “Buy”. The firm has “Underperform” rating by Jefferies given on Wednesday, December 16. The rating was upgraded by DA Davidson to “Buy” on Monday, December 5. KeyBanc Capital Markets initiated the shares of SAFM in report on Friday, December 2 with “Sector Weight” rating. The rating was downgraded by Goldman Sachs to “Sell” on Tuesday, March 15. The stock of Sanderson Farms, Inc. (NASDAQ:SAFM) earned “Overweight” rating by JP Morgan on Monday, January 11. As per Thursday, August 18, the company rating was upgraded by CLSA.
New Amsterdam Partners Llc decreased Wabco Hldgs Inc (NYSE:WBC) stake by 6,384 shares to 48,626 valued at $5.16M in 2016Q4. It also reduced Select Med Hldgs Corp (NYSE:SEM) stake by 514,559 shares and now owns 115,998 shares. Mettler Toledo International (NYSE:MTD) was reduced too.
Investors sentiment increased to 1.32 in Q4 2016. Its up 0.09, from 1.23 in 2016Q3. It is positive, as 35 investors sold SAFM shares while 71 reduced holdings. 47 funds opened positions while 93 raised stakes. 22.45 million shares or 6.60% more from 21.06 million shares in 2016Q3 were reported. Parallax Volatility Advisers Lp holds 0% in Sanderson Farms, Inc. (NASDAQ:SAFM) or 589 shares. Shell Asset Management Company, a Netherlands-based fund reported 20,597 shares. Victory invested in 938,156 shares or 0.22% of the stock. Geode Cap Mngmt Ltd Liability has 0.01% invested in Sanderson Farms, Inc. (NASDAQ:SAFM). Northwestern Mutual Wealth Mgmt stated it has 0% in Sanderson Farms, Inc. (NASDAQ:SAFM). Goldman Sachs Gru reported 120,658 shares. Nuance Invests Lc invested 0.65% in Sanderson Farms, Inc. (NASDAQ:SAFM). Citadel Advsr Limited Liability Corporation owns 157,280 shares for 0.01% of their portfolio. Quantbot Tech Lp accumulated 1,042 shares. Weaver C Barksdale & Assoc accumulated 31 shares. Dimensional Fund Advsr Lp holds 0.05% or 963,069 shares. Smithfield has 0% invested in Sanderson Farms, Inc. (NASDAQ:SAFM). 21,235 were accumulated by Systematic Fincl Limited Partnership. Parkside National Bank And reported 12 shares. 4,342 were reported by Mason Street Advsr Ltd.
Since February 24, 2017, it had 0 buys, and 4 insider sales for $924,333 activity. On Monday, March 6 LIVINGSTON PHIL K sold $157,391 worth of Sanderson Farms, Inc. (NASDAQ:SAFM) or 1,700 shares. The insider KHAYAT ROBERT C sold 1,210 shares worth $113,510. The insider Bierbusse John sold 750 shares worth $70,658. Another trade for 5,619 shares valued at $582,774 was sold by COCKRELL D MICHAEL.
REGENXBIO Inc. is a clinical-stage biotechnology company. The company has market cap of $612.55 million. The Company’s gene therapy product candidates are designed to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. It currently has negative earnings. The Firm develops products candidates across the therapeutic areas of metabolic, neurodegenerative and retinal diseases.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.